Artivion, a medical device company specializing in cardiac and vascular surgery products, announced it will release its third quarter 2026 financial results on November 5, 2026, after market close. The company will host a teleconference and live webcast at 4:30 p.m. ET to discuss the results, followed by a Q&A session led by CEO Pat Mackin. Investors can access the webcast and replay via Artivion's website. This earnings release will provide insights into the company's performance and outlook for the year.
Artivion's upcoming third quarter 2026 financial results provide context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 23, 2026 02:41 WIB: out of 150 priced US health-sector stocks, 77 rose and 71 fell. Notable movers include NVAX at USD 10.05 with a 1-day change of -8.72% and Pluang order activity of 76% Sell / 24% Buy, NUWE at USD 0.48 down 7.94% with 0% Sell / 100% Buy activity, and SLS at USD 11.21 down 7.66%.
Share-ify introduced the S.A.F.E. Score™, an AI-powered forecasting engine designed to enhance supplier risk intelligence within its food safety and compliance solutions. This tool analyzes diverse data such as audit results, recall history, and insp...
EquipmentShare, a major U.S. construction equipment rental and technology provider, will announce its fiscal third quarter 2026 financial results after market close on November 9, 2026. The company will host a conference call for investors and analys...
Atlantic American Corporation received a Nasdaq Staff Delisting Determination due to missing its 2025 annual and 2026 quarterly SEC reports by the extended October 12 deadline. The company has since filed the 2025 annual report and is working to subm...
Randstad reported revenue and earnings that exceeded expectations, driven by improving business trends and key labor markets. This positive performance signals momentum in the employment services sector. RBC Capital maintained a 'Sector Perform' rati...
MSC Industrial Supply reported strong Q4 results with revenue rising 10.3% year-over-year to about $1.08 billion, surpassing estimates. Adjusted earnings per share increased to $1.45 from $1.09, also beating expectations. Full-year sales grew 6.4% to...
